Additionally, our results demonstrated that the level of AGTRAP was significantly correlated with patient weight, especially BMI ≥ 30 kg/m2, suggesting that obese patients may have a higher risk of HCC. Here, AGTRAP is linked to hepatocellular carcinoma.